Clinical trials
Immunoglobulin Light-chain Amyloidosis trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking Union Medical College Hospital | 2 |
| Air Force Military Medical University, China | 1 |
| Attralus, Inc. | 1 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Cedars-Sinai Medical Center | 1 |
| Guangdong Provincial People's Hospital | 1 |
| Intergroupe Francophone du Myelome | 1 |
| Medical College of Wisconsin | 1 |
| Midwest Heart & Vascular Specialists | 1 |
| Nanjing University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immunoglobulin Light-chain Amyloidosis | 15 |
| Burkitt Lymphoma | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma, B-Cell, Marginal Zone | 3 |
| Lymphoma, Follicular | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Lymphoma, Large-Cell, Immunoblastic | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Multiple Myeloma | 3 |
Trials
Showing 51 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.